These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 51627)

  • 41. Immunological characteristics of leukemia and lymphoma in allogeneic cell immunity: growth of syngeneic tumors in rats immunized with allogeneic cells.
    Hosokawa M; Yamashita T; Gotohda E; Takeichi N; Kodama T; Kobayashi H
    Int J Cancer; 1978 Jul; 22(1):91-7. PubMed ID: 681026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct comparison of three isotopic release microtoxicity assays as measures of cell-mediated immunity to Gross virus-induced lymphomas in rats.
    Oldham RK; Ortaldo JR; Holden HT; Herberman RB
    J Natl Cancer Inst; 1977 Apr; 58(4):1061-7. PubMed ID: 300436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss and recovery of phenotypic expression of Gross leukaemia virus.
    Ioachim HL; Dorsett B; Sabbath M; Keller S
    Nat New Biol; 1972 Jun; 237(76):215-8. PubMed ID: 4113835
    [No Abstract]   [Full Text] [Related]  

  • 44. Measurement of Gross cell-surface antigen and p30 level in murine retrovirus-infected cell lines.
    Gerlier D; Gisselbrecht S; Guillemain B; Doré JF
    Br J Cancer; 1981 May; 43(5):659-68. PubMed ID: 7248150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for long-lasting tumor immunity in a syngeneic rat lymphoma model: correlation of in vitro findings with in vivo observations.
    Oehler JR; Herberman RB
    J Natl Cancer Inst; 1979 Mar; 62(3):525-9. PubMed ID: 153984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterogenization of normal tissues in oncogenesis. A skeptical review.
    Mariani T; Good RA
    Isr J Med Sci; 1973 Mar; 9(3):380-94. PubMed ID: 4575655
    [No Abstract]   [Full Text] [Related]  

  • 47. Synergy in proliferative and cytotoxic responses of WF rats to syngeneic Gross virus-induced lymphoma cells in vitro.
    Wright PW; Loop SM; Bernstein ID
    J Natl Cancer Inst; 1980 Feb; 64(2):303-8. PubMed ID: 6965510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of the cellular immune response to Gross virus-induced lymphoma by the mixed lymphocyte-tumor interaction.
    Glaser M; Herberman RB; Kirchner H; Djeu JY
    Cancer Res; 1974 Sep; 34(9):2165-71. PubMed ID: 4276482
    [No Abstract]   [Full Text] [Related]  

  • 49. Gross-virus-induced lymphoma in the rat. IV. Cytotoxic cells in normal rats.
    Shellam GR; Hogg N
    Int J Cancer; 1977 Feb; 19(2):212-24. PubMed ID: 838521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppressor mechanisms in neonatally acquired tolerance to a Gross virus-induced lymphoma in rats.
    Myburgh JA; Mitchison NA
    Transplantation; 1976 Sep; 22(3):236-44. PubMed ID: 135385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Redistribution and modulation of Gross murine leukemia virus antigens induced by specific antibodies.
    Ioachim HL; Sabbath M
    J Natl Cancer Inst; 1979 Jan; 62(1):169-80. PubMed ID: 281570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 54. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 55. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
    Jones DB; Moore M
    Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

  • 59. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.
    Schirrmacher V; Bosslet K; Shantz G; Clauer K; Hübsch D
    Int J Cancer; 1979 Feb; 23(2):245-52. PubMed ID: 83969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Immunol; 1974 Jun; 112(6):2102-10. PubMed ID: 4825787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.